ArticleJournal for immunotherapy of cancer2022

Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng

Vidya Sankar Viswanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.